© 1999 by European Society of Cardiology
Copyright © 1999, European Society of Cardiology
Nitric oxide controls cardiac substrate utilization in the conscious dog
Department of Physiology, New York Medical College, Valhalla, NY 10595, USA
* Corresponding author. Tel.: +1-914-594-3633; fax: +1-914-594-4018 Thomas_Hintze{at}nymc.edu
Objectives: The aim of this study was to determine whether the acute inhibition of nitric oxide (NO) synthase causes changes in cardiac substrate utilization which can be reversed by a NO donor. Methods: NO synthase was blocked by giving 30 mg/kg of nitro-L-arginine (NLA) i.v. to 15 chronically instrumented dogs. Hemodynamics and blood samples from aorta and coronary sinus were taken at control and at 1 and 2 h after NLA. In five dogs, 0.4 mg/kg of the NO donor 3754 was given i.v. 1 h after NLA. In six dogs, angiotensin II was infused over 2 h (20–40 ng/kg/min) to mimic the hemodynamic effects of NLA. Results: Two h after NLA: mean arterial pressure was 153±4 mmHg; MVO2 increased by 38%; cardiac uptake of lactate and glucose increased, respectively, from 20.0±5.0 to 41.0±9.3 µmol/min and from 1.1±0.7 to 6.8±1.5 mg/min (all P<0.05 vs. control). Cardiac uptake of free fatty acids decreased by 43% after 1 h (P<0.05) and returned to control values at 2 h. Cardiac respiratory quotient increased from 0.76±0.03 to 1.05±0.07, indicating a shift to carbohydrate oxidation. All these changes were reversed by the NO donor. In the dogs receiving angiotensin II infusion, MVO2 increased by 28% and lactate uptake doubled (both P<0.05), but no other metabolic changes where observed. Conclusions: The acute inhibition of NO synthase by NLA causes a switch from fatty acids to lactate and glucose utilization by the heart which can be reversed by a NO donor, suggesting an important regulatory action of NO on cardiac metabolism.
KEYWORDS Energy metabolism; Hemodynamics; Nitric oxide; Oxygen consumption
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Serpillon, B. C. Floyd, R. S. Gupte, S. George, M. Kozicky, V. Neito, F. Recchia, W. Stanley, M. S. Wolin, and S. A. Gupte Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H153 - H162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Misfeldt, A. Fago, and H. Gesser Nitric oxide increases myocardial efficiency in the hypoxia-tolerant turtle Trachemys scripta J. Exp. Biol., April 1, 2009; 212(7): 954 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Williams, C. Ojaimi, K. Qanud, S. Zhang, X. Xu, F. A. Recchia, and T. H. Hintze Coronary nitric oxide production controls cardiac substrate metabolism during pregnancy in the dog Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2516 - H2523. [Abstract] [Full Text] [PDF]
|
|